Work

Top advances of the year: The status of chimeric antigen receptor T cells in neuro‐oncology

Year: 2025

Type: article

Abstract: Numerous major advances have been made in the past year regarding chimeric antigen receptor (CAR) T‐cell therapy in neuro‐oncology. Disialoganglioside GD2 CAR T cells, bivalent CAR T cells, and CARv3–engineered T cells expressing a T‐cell–engaging antibody molecule all show promise for diffuse midline glioma and glioblastoma.

Source: Cancer

DOI: 10.1002/cncr.35935

Authors: Ravi Medikonda, Matthew A. Abikenari, Ethan Schonfeld, Michael Lim

Institutions: Stanford Medicine, Stanford University

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4411123827

FWCI: 2.877

Cites: 32

Cited by: 8

Related to: 10